5 Best Dividend Paying Stocks To Buy Now

Page 1 of 5

In this article, we discuss 5 best dividend-paying stocks to buy now. If you want to read our detailed analysis of dividend stocks and their returns, go directly to read 11 Best Dividend Paying Stocks To Buy Now

5. UnitedHealth Group Incorporated (NYSE:UNH)

Number of Hedge Fund Holders: 91
Dividend Yield as of September 26: 1.30%

UnitedHealth Group Incorporated (NYSE:UNH) is a Minnesota-based multinational managed healthcare and insurance company that provides insurance services and healthcare products to its consumers. The company has been paying uninterrupted quarterly dividends since 2010 and paid annual dividends before that for 20 years. Currently, it pays a quarterly dividend of $1.65 per share, with a dividend yield of 1.30%, as of September 26.

In September, Raymond James raised its price target on UnitedHealth Group Incorporated (NYSE:UNH) to $635 with a Strong Buy rating on the shares, as the company’s deal with Change Healthcare reaches its final stage.

At the end of Q2 2022, 91 hedge funds in Insider Monkey’s database owned stakes in UnitedHealth Group Incorporated (NYSE:UNH) in Q2, with a total value of roughly $11 billion. GQG Partners owned $1.6 billion worth of stakes in the company, becoming its leading stakeholder in Q2 2022.

Baron Funds mentioned UnitedHealth Group Incorporated (NYSE:UNH) in its Q2 2022 investor letter. Here is what the firm has to say:

UnitedHealth Group Incorporated is a leading diversified health and wellbeing company whose divisions include insurance arm, United Healthcare and health care services arm, Optum, which offers care delivery and other services. Shares increased 1.1% on strong first quarter results (revenues were up 14% year-over-year), and the company increased its annual guidance.

The performance was driven by Optum as a result of a growing adoption of value-based solutions. We believe UnitedHealth leads the health care industry in innovation and execution as evidenced by its strong value proposition leading to Medicare Advantage share gains, strong cost controls, and its leadership position in the shift to value-based care.”


Page 1 of 5